Trial · NCT06956885
Registered outcomes77
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 40 of 77
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | US features of gout at knees | At 18 months | Double contour sign for withdrawal arm |
| Secondary | US features of gout at knees | At 24 months | Double contour sign for both arms |
| Secondary | US features of gout at knees | At 30 months | Double contour sign for withdrawal arm |
| Secondary | US features of gout at knees | At 36 months | Double contour sign for withdrawal arm |
| Secondary | Urate levels | At 6 months | |
| Secondary | Urate levels | At 12 months | |
| Secondary | Urate levels | At 18 months | |
| Secondary | Urate levels | At 24 months | |
| Secondary | Urate levels | At 30 months | |
| Secondary | Urate levels | At 36 months | |
| Secondary | Change from baseline of patient's global assessment of disease activity | At 12 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies 0-5-point Likert scale, the higher the score the more severe the disease |
| Secondary | Change from baseline of patient's global assessment of disease activity | At 24 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies 0-5-point Likert scale, the higher the score the more severe the disease |
| Secondary | Change from baseline of patient's global assessment of disease activity | At 36 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies 0-5-point Likert scale, the higher the score the more severe the disease |
| Secondary | Change from baseline in Healthrelated quality of life | At 12 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies EuroQol 5-domain-3L (EQ-5D3L) questionnaire The QLQ-C30 is composed of both multi-item scales and single-item measures. These include five functional scales, three symptom scales, a global health status / QoL scale, and six single items. Each of the multi-item scales includes a different set of items - no item occurs in more than one scale. All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. A high score for a functional scale represents a high/healthy level of functioning. A high score for the global health status/ QoL represents a high QoL and a high score for a symptom scale/item represents a high level of symptomatology/problems |
| Secondary | Change from baseline in Healthrelated quality of life | At 24 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies EuroQol 5-domain-3L (EQ-5D3L) questionnaire The QLQ-C30 is composed of both multi-item scales and single-item measures. These include five functional scales, three symptom scales, a global health status / QoL scale, and six single items. Each of the multi-item scales includes a different set of items - no item occurs in more than one scale. All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. A high score for a functional scale represents a high/healthy level of functioning. A high score for the global health status/ QoL represents a high QoL and a high score for a symptom scale/item represents a high level of symptomatology/problems |
| Secondary | Change from baseline in Healthrelated quality of life | At 36 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies EuroQol 5-domain-3L (EQ-5D3L) questionnaire The QLQ-C30 is composed of both multi-item scales and single-item measures. These include five functional scales, three symptom scales, a global health status / QoL scale, and six single items. Each of the multi-item scales includes a different set of items - no item occurs in more than one scale. All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. A high score for a functional scale represents a high/healthy level of functioning. A high score for the global health status/ QoL represents a high QoL and a high score for a symptom scale/item represents a high level of symptomatology/problems |
| Secondary | Change from baseline in Activity limitation | At 12 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies Health Assessment Questionnaire II is a 10-item score. Each item is rated on a 4-point Likert scale HAQ-II mean score ranges from 0 (no disability) to 3 (severe disability) |
| Secondary | Change from baseline in Activity limitation | At 24 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies Health Assessment Questionnaire II is a 10-item score. Each item is rated on a 4-point Likert scale HAQ-II mean score ranges from 0 (no disability) to 3 (severe disability) |
| Secondary | Change from baseline in Activity limitation | At 36 months | Outcome Measures in Rheumatology (OMERACT) core outcome domains for long-term gout studies Health Assessment Questionnaire II is a 10-item score. Each item is rated on a 4-point Likert scale HAQ-II mean score ranges from 0 (no disability) to 3 (severe disability) |
| Secondary | Incidence of Major CardioVascular events | At 6 months | Including nonfatal stroke, nonfatal myocardial infarction, cardiovascular death |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06956885/registered?page=2